Prospects for improving African trypanosomiasis chemotherapy

被引：14
作者：
Moore, AC [1 ]
机构：
[1] Ctr Dis Control & Prevent, Div Parasit Dis, Natl Ctr Infect Dis, Atlanta, GA 30341 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2005年 / 191卷 / 11期
关键词：
D O I：
10.1086/429935
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1793 / 1795
页数：3
相关论文
共 30 条
[1]   TREATMENT OF ARSENICAL REFRACTORY RHODESIAN SLEEPING SICKNESS IN KENYA [J].
BALES, JD ;
HARRISON, SM ;
MBWABI, DL ;
SCHECTER, PJ .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1989, 83 :111-114
[2]   The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes [J].
Barrett, MP ;
Fairlamb, AH .
PARASITOLOGY TODAY, 1999, 15 (04) :136-140
[3]   The phenomenon of treatment failures in Human African Trypanosomiasis [J].
Brun, R ;
Schumacher, R ;
Schmid, C ;
Kunz, C ;
Burri, C .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (11) :906-914
[4]   Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense:: a randomised trial [J].
Burri, C ;
Nkunhu, S ;
Merolle, A ;
Smith, T ;
Blum, J ;
Brun, R .
LANCET, 2000, 355 (9213) :1419-1425
[5]   Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment [J].
Burri, C ;
Keiser, J .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2001, 6 (05) :412-420
[6]   PHARMACOKINETICS OF MELARSOPROL IN UNINFECTED VERVET MONKEYS [J].
BURRI, C ;
ONYANGO, JD ;
AUMA, JE ;
BURUDI, EME ;
BRUN, R .
ACTA TROPICA, 1994, 58 (01) :35-49
[7]   PHARMACOKINETIC PROPERTIES OF THE TRYPANOCIDAL DRUG MELARSOPROL [J].
BURRI, C ;
BALTZ, T ;
GIROUD, C ;
DOUA, F ;
WELKER, HA ;
BRUN, R .
CHEMOTHERAPY, 1993, 39 (04) :225-234
[8]   ARSENICAL-RESISTANT TRYPANOSOMES LACK AN UNUSUAL ADENOSINE TRANSPORTER [J].
CARTER, NS ;
FAIRLAMB, AH .
NATURE, 1993, 361 (6408) :173-176
[9]  
*DNDI, 2003, DNDIS R D PORTF
[10]  
GASTELLUETCHEGO.M, 2001, TROP MED INT HEALTH, V6, P957
123